Home / Resource Library / Janus kinases restrain chronic lymphocytic leukemia cells in patients on ibrutinib: Results of a phase II trial

Janus kinases restrain chronic lymphocytic leukemia cells in patients on ibrutinib: Results of a phase II trial

Results of a study investigating ruxolitinib combined with rituximab for treatment of CLL